Application of FSME-Immun and Epaxal in allergic patients

Trial Profile

Application of FSME-Immun and Epaxal in allergic patients

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 02 Apr 2013

At a glance

  • Drugs Tick-borne encephalitis vaccine (Primary) ; Hepatitis A vaccine inactivated
  • Indications Encephalitis virus infections; Hepatitis A; Hypersensitivity
  • Focus Therapeutic Use
  • Acronyms FSME-Epaxal-allergic patients
  • Most Recent Events

    • 02 Apr 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top